Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Head and Neck Cancers
•
Radiation Oncology
What is the significance of LVSI in determining post-op management for oropharyngeal cancer?
Would you recommend PORT based on LVSI as the sole risk factor (i.e. pT1/T2N0 OP SCCa)?
Answer from: Radiation Oncologist at Academic Institution
It doesn’t change my management.
Sign in or Register to read more
17974
Related Questions
How do you consider the role of probiotics for mucositis mitigation in patients receiving head and neck radiotherapy?
What is the recommended adjuvant dose for neuroendocrine cancer in the head and neck?
How do you treat SNUC?
For locally advanced adenocarcinoma of the maxillary sinus, how should the neck be managed?
How would you approach SCC of unknown primary, p16-, EBV-, metastatic to a large 5.5 cm level 2 neck node, if you suspect a cutaneous origin after clinical workup?
What is the role of radiation therapy for an elderly patient with medullary thyroid cancer who is not a surgical candidate?
What is the recommended treatment approach for stage III/IVA nasopharyngeal cancer that is p16 negative and EBV positive?
Is there a role for prophylactic Trental and vitamin E in a patient at high risk for osteoradionecrosis?
What would be your approach to the treatment of limited stage extrapulmonary small cell carcinoma of the nasopharynx with bilateral cervical lymphadenopathy?
Do you recommend radioactive iodine for Hürthle Cell thyroid carcinoma?